SCHEMBL4662858

SCHEMBL4662858

COc1cccc(CNS(=O)(=O)c2ccccc2)c1

nearest known ligand 0.74

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.74
ALDH1A1 P00352 4/20 0.71
MEN1 O00255 2/20 0.67
GAA P10253 2/20 0.67
KMT2A Q03164 2/20 0.67
POLB P06746 2/20 0.67
KEAP1 Q14145 1/20 0.63
MAPT P10636 1/20 0.62
NAMPT P43490 1/20 0.57
AKR1C3 P42330 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
ROCK1 Q13464 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10047336 0.89 CYP19A1 (0.76) CYP19A1ALDH1A1MEN1GAAKMT2A
SCHEMBL20946439 0.87 CYP19A1 (0.72) CYP19A1ALDH1A1MEN1GAAKMT2A
SCHEMBL12813108 0.87 CYP19A1 (0.76) CYP19A1ALDH1A1MEN1GAAKMT2A
SCHEMBL5444156 0.87 CYP19A1 (0.72) CYP19A1ALDH1A1MEN1GAAKMT2A
SCHEMBL30504862 0.87 CYP19A1 (0.72) CYP19A1ALDH1A1MEN1GAAKMT2A
SCHEMBL9813024 0.86 AKR1C3 (0.76) ALDH1A1GAAPOLBMAPTAKR1C3
SCHEMBL5455007 0.86 CYP19A1 (0.66) CYP19A1ALDH1A1MEN1GAAKMT2A
SCHEMBL5130325 0.86 AKR1C3 (0.79) CYP19A1ALDH1A1MEN1GAAKMT2A
SCHEMBL26229835 0.85 CYP19A1 (0.69) CYP19A1ALDH1A1MEN1GAAKMT2A
SCHEMBL21048461 0.84 KEAP1 (0.81) CYP19A1KEAP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107820429-B Novel compositions and methods for immunotherapy comprising small molecule integrin receptor-ligand agonist adjuvants 7山药物有限责任公司 2022-08-16 CN disclosed
CN-107820429-A Include the new compositions and method for immunization therapy of small molecule integrin receptors ligand activator adjuvant 7山利益有限责任公司 2018-03-20 CN disclosed
CN-100548979-C A kind of method of synthetic 3-methyl amino indole compound SHANGHAI INST ORGANIC CHEM (CN) 2009-10-14 CN disclosed
EP-2007760-A1 NOVEL SUBSTITUTED-1, 1-DIOXO-BENZO[1,2,4]THIADIZIN-3-ONES, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-12-31 EP disclosed
WO-2007108569-A1 NOVEL SUBSTITUTED-1, 1-DIOXO-BENZO[1,2,4]THIADIZIN-3-ONES, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME KOREA RESERACH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2007-09-27 WO disclosed
CN-100999490-A Process of synthesizing 3-methyl amino indole compound SHANGHAI INST OF ORGANIST CHEM (CN) 2007-07-18 CN disclosed
EP-1443041-A1 5-AMIDINO-2-HYDROXYBENZENESULFONAMIDE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME, MEDICINAL USE THEREOF AND INTERMEDIATES IN THE PRODUCTION THEREOF Kissei Pharmaceutical Co., Ltd. (JP) 2004-08-04 EP disclosed